Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DIVIS LABORATORIES   MYLAN
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
MYLAN
Dec-18
DIVIS LABORATORIES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs4,6413,967-   
Low Rs2,7302,184-   
Sales per share (Unadj.) Rs292.61,825.4-  
Earnings per share (Unadj.) Rs68.749.6-  
Cash flow per share (Unadj.) Rs81.6391.3-  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs480.91,974.7-  
Shares outstanding (eoy) m265.47514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.61.7 747.7%   
Avg P/E ratio x53.762.0 86.5%  
P/CF ratio (eoy) x45.27.9 574.7%  
Price / Book Value ratio x7.71.6 492.1%  
Dividend payout %43.70-   
Avg Mkt Cap Rs m978,3781,582,214 61.8%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m9,7500-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m77,675939,158 8.3%  
Other income Rs m3,4470-   
Total revenues Rs m81,122939,158 8.6%   
Gross profit Rs m23,691243,019 9.7%  
Depreciation Rs m3,432175,847 2.0%   
Interest Rs m2045,170 0.0%   
Profit before tax Rs m23,68622,002 107.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,453-3,500 -155.8%   
Profit after tax Rs m18,23425,502 71.5%  
Gross profit margin %30.525.9 117.9%  
Effective tax rate %23.0-15.9 -144.7%   
Net profit margin %23.52.7 864.5%  
BALANCE SHEET DATA
Current assets Rs m97,437524,425 18.6%   
Current liabilities Rs m15,331382,364 4.0%   
Net working cap to sales %105.715.1 698.8%  
Current ratio x6.41.4 463.4%  
Inventory Days Days884 10.0%  
Debtors Days Days84293 902.7%  
Net fixed assets Rs m51,128182,181 28.1%   
Share capital Rs m531500 106.2%   
"Free" reserves Rs m127,1400-   
Net worth Rs m127,6711,015,998 12.6%   
Long term debt Rs m01,096,588 0.0%   
Total assets Rs m148,5652,725,301 5.5%  
Interest coverage x1,209.51.5 81,332.6%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.50.3 151.7%   
Return on assets %12.32.6 473.8%  
Return on equity %14.32.5 569.0%  
Return on capital %18.63.2 584.0%  
Exports to sales %85.70-   
Imports to sales %19.80-   
Net fx Rs m50,8220-   
CASH FLOW
From Operations Rs m24,597195,157 12.6%  
From Investments Rs m-27,076-100,875 26.8%  
From Financial Activity Rs m-7,972-90,916 8.8%  
Net Cashflow Rs m-10,4511,617 -646.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare DIVIS LABORATORIES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DIVIS LABORATORIES With: LYKA LABS  GUJ.THEMIS.  BLISS GVS PHARMA  JFL LIFE SCIENCES LTD.  PARNAX LAB  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.